EDGAR Filing Documents for 0001628280-17-006845

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001628280-17-006845

Filing Date

2017-06-29

Accepted

2017-06-29 17:31:09

Documents

Period of Report

2017-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	a033117rasna10-kproject.htm	10-K	1405929
2	EXHIBIT 3.2	a03312017rasnaexhibit32.htm	EX-3.2	214752
3	EXHIBIT 14	a03312017rasnaexhibit14.htm	EX-14	168432
4	EXHIBIT 21	a03312017rasnaexhibit21.htm	EX-21	33853
5	EXHIBIT 31.1	a03312017rasnaexhibit311.htm	EX-31.1	14117
6	EXHIBIT 31.2	a03312017rasnaexhibit312.htm	EX-31.2	14071
7	EXHIBIT 32.1	a03312017rasnaexhibit321.htm	EX-32.1	5266
8	EXHIBIT 32.2	a03312017rasnaexhibit322.htm	EX-32.2	5572
	Complete submission text file	0001628280-17-006845.txt		6605448

Data Files

Seq	Description	Document	Type	Size
9	XBRL INSTANCE DOCUMENT	rasp-20170331.xml	EX-101.INS	1113113
10	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	rasp-20170331.xsd	EX-101.SCH	50400
11	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	rasp-20170331_cal.xml	EX-101.CAL	61968
12	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	rasp-20170331_def.xml	EX-101.DEF	211178
13	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	rasp-20170331_lab.xml	EX-101.LAB	627291
14	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	rasp-20170331_pre.xml	EX-101.PRE	379593

Mailing Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170

Business Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170 646-396-4087

Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)